Dr. Hae Lin Jang is an Assistant Professor at Brigham and Women’s Hospital and Harvard Medical School. She is the Principal Investigator of Jang’s Laboratory for Developing Advanced Biomaterials and Biotechnologies. Her research is based at the interface of materials science, nanotechnology, biochemistry, and tissue engineering to develop functional hybrid biomaterials and biotechnologies for the treatment of incurable diseases. She was the first to develop a facile synthetic method of whitlockite (Ca18Mg2(HPO4)2(PO4)12) nanoparticles, which is the second most abundant biocrystal in the human body.
In addition, she designed and built tree-like dimension tunable nanochannels in bioceramic scaffolds, to promote fluid and nutrient supply. She also created several organic-inorganic hybrid biomaterials for biomedical applications, including cotton-like, drug loadable biodegradable materials for wound healing and hydroxyapatite (Ca10(PO4)6(OH)2)-coated polyetheretherketone (PEEK) hybrid material to overcome the inertness of PEEK to treat degenerative spine diseases.
She has also developed advanced biotechnologies to recapitulate sophisticated cellular structures of human tissues using 3D bioprinting and microfluidic organ-on-a-chip.